MinuteClinic opens first retail clinic in D.C.
WASHINGTON MinuteClinic, the retail-based healthcare system owned by CVS Caremark, has opened its first retail healthcare center in Washington, D.C., inside a CVS/pharmacy.
The clinic is open seven days a week and will serve patients in Northeast neighborhoods, including Trinidad, Carver Langston, Kingman Park, Atlas District, Ivy City and the Gallaudet University campus.
The MinuteClinic healthcare center in Northeast is located at 845 Bladensburg Road and is open Monday through Friday from 8:30 a.m. to 7:30 p.m., Saturday from 9 a.m. to 5:30 p.m. and Sunday from 10 a.m. to 5:30 p.m.
“Through this conveniently located store-based clinic, we are expanding access to high-quality, affordable care for common family illnesses in the Northeast neighborhoods of the District of Columbia,” said Andrew Sussman, M.D., MinuteClinic president. “We are committed to making our innovative model, which includes a series of prevention and wellness services, part of the District’s extensive efforts to broaden access to quality medical care for its citizens.”
Additional MinuteClinic locations are expected to open inside CVS/pharmacy stores in the District of Columbia in 2010. There are 23 MinuteClinic healthcare centers inside select CVS/pharmacy stores in Northern Virginia and Maryland counties surrounding the District of Columbia.
FDA approves Pharmaforce’s dorzolamide hydrochloride eye drops
ROCKVILLE, Md. The Food and Drug Administration has approved a drug for treating high pressure in the eye, a condition that eventually can lead to blindness.
FDA records show that the agency approved Pharmaforce’s dorzolamide hydrochloride eye drops.
The drug is used to treat high pressure in the eye resulting from open-angle glaucoma and ocular hypertension and is a generic version of Merck & Co.’s Trusopt.
FDA approves Amneal’s GERD generic
ROCKVILLE, Md. The Food and Drug Administration has approved a generic version of a drug for treating gastroesophageal reflux disease in adolescents and adults.
According to FDA records, the agency approved Amneal Pharmaceuticals’ nizatidine oral solution in the 15-mg-per-15-mL strength.
The drug is used to treat symptoms of GERD in patients ages 12 years and older and is a generic version of Axid, made by Braintree Laboratories.